VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 410 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2013. The put-call ratio across all filers is 0.62 and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $4,000 | +33.3% | 200 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $3,000 | -25.0% | 200 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $4,000 | +100.0% | 200 | 0.0% | 0.00% | – |
Q3 2017 | $2,000 | 0.0% | 200 | 0.0% | 0.00% | – |
Q2 2017 | $2,000 | 0.0% | 200 | 0.0% | 0.00% | -100.0% |
Q1 2017 | $2,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $2,000 | -50.0% | 200 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $4,000 | -92.0% | 200 | -92.1% | 0.00% | -93.3% |
Q2 2016 | $50,000 | -97.3% | 2,530 | -96.4% | 0.02% | -97.3% |
Q1 2016 | $1,863,000 | -75.2% | 70,854 | -4.2% | 0.56% | -74.1% |
Q4 2015 | $7,516,000 | -47.3% | 73,938 | -7.5% | 2.17% | -44.9% |
Q3 2015 | $14,263,000 | -21.7% | 79,960 | -2.5% | 3.94% | -8.7% |
Q2 2015 | $18,227,000 | +6.2% | 82,049 | -5.1% | 4.31% | +6.2% |
Q1 2015 | $17,170,000 | +38.0% | 86,446 | -0.6% | 4.06% | +37.5% |
Q4 2014 | $12,444,000 | +4.0% | 86,952 | -4.6% | 2.95% | +4.2% |
Q3 2014 | $11,962,000 | +1.8% | 91,176 | -2.1% | 2.83% | +2.8% |
Q2 2014 | $11,746,000 | -3.1% | 93,131 | +1.3% | 2.76% | -5.7% |
Q1 2014 | $12,116,000 | +19.6% | 91,908 | +6.5% | 2.92% | +10.3% |
Q4 2013 | $10,130,000 | +8.8% | 86,285 | -3.3% | 2.65% | +1.4% |
Q3 2013 | $9,314,000 | +29.7% | 89,270 | +7.0% | 2.62% | +26.5% |
Q2 2013 | $7,180,000 | – | 83,405 | – | 2.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |